All articles by Milena Izmirlieva

Milena Izmirlieva

Pricing and Market Access

Precise magnitude of hospital markups revealed in the US

A recent study has shed light on the size of markups imposed by hospitals for parenteral cancer drugs in the US.

Pricing and Market Access

Delta variant prompts change in policy responses

Pricing and Market Access

Reimbursement outcomes for combination therapies in breast cancer

Pricing and Market Access

Vaccine hesitancy boosts risks from vaccine nationalism

Pricing and Market Access

Trump resurrects International Reference Pricing (IRP) proposal on pharmaceuticals with executive order

Pricing and Market Access

COVID-19 pandemic: Health system surge capacity

Pricing and Market Access

Risks to UK pharmaceutical spending from a US-UK free trade deal

Pricing and Market Access

Challenges with risk sharing in Eastern Europe raised at ISPOR Europe meeting

Pricing and Market Access

United States experience dramatic shift in public share of healthcare spending

Pricing and Market Access

Our pricing and reimbursement research presented at ISPOR Europe